semaglutide als GLP-1 receptor agonists, mimicking an intestinal hormone, regulate blood sugar by increasing insulin, suppressing glucagon, reducing appetite, and delaying gastric emptying. Originally developed for Type 2 diabetes and obesity, drugs like The promise of GLP-1 receptor

Dry eye is common and often goes away on its own

Three major reviews commissioned by the World Health Organization find that GLP-1 drugs including tirzepatide (sold as Mounjaro and Zepbound), semaglutide (Ozempic and Wegovy), and liraglutide (Victoza and Saxenda) can lead to substantial weight loss in people with obesity

Minimize Semaglutide side effects with expert tips on dosage adjustments, hydration, diet modifications, and lifestyle changes for better tolerance and results.

Here, we report a unique case of semaglutide-induced pancreatitis complicated by distributive shock and death after four years of use

The recent approval of semaglutide for weight loss has influenced many people to search for ways to be prescribed this wonderful weight loss drug.